Dr. Paul Pellicci: Oncology Visionary And Revolutionary In Biotechnology
Dr. Paul Pellicci, an oncology visionary, has made transformative contributions to the field. As CEO of Halozyme and Forty Seven, he revolutionized biotechnology and oncology. His pioneering research in protein engineering and drug delivery led to the development of PEGPH20. His expertise in antibody-drug conjugates shaped targeted cancer therapies. As a member of the National…